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Abstract
Human papillomaviruses (HPVs) are maintained latently in dividing epithelial cells as nuclear plasmids. Two virally encoded proteins, E1, a
helicase, and E2, a transcription factor, are important players in replication and stable plasmid maintenance in host cells. Recent experiments in
yeast have demonstrated that viral genomes retain replication and maintenance function independently of E1 and E2 [Angeletti, P.C., Kim, K.,
Fernandes, F.J., and Lambert, P.F. (2002). Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J. Virol. 76(7), 3350-8;
Kim, K., Angeletti, P.C., Hassebroek, E.C., and Lambert, P.F. (2005). Identification of cis-acting elements that mediate the replication and
maintenance of human papillomavirus type 16 genomes in Saccharomyces cerevisiae. J. Virol. 79(10), 5933-42]. Flow cytometry studies of
EGFP-reporter vectors containing subgenomic HPV fragments with or without a human ARS (hARS), revealed that six fragments located in E6–
E7, E1–E2, L1, and L2 regions showed a capacity for plasmid stabilization in the absence of E1 and E2 proteins. Interestingly, four fragments
within E7, the 3′ end of L2, and the 5′ end of L1 exhibited stability in plasmids that lacked an hARS, indicating that they possess both replication
and maintenance functions. Two fragments lying in E1–E2 and the 3′ region of L1 were stable only in the presence of hARS, that they contained
only maintenance function. Mutational analyses of HPV16-GFP reporter constructs provided evidence that genomes lacking E1 and E2 could
replicate to an extent similar to wild type HPV16. Together these results support the concept that cellular factors influence HPV replication and
maintenance, independently, and perhaps in conjunction with E1 and E2, suggesting a role in the persistent phase of the viral lifecycle.
© 2008 Elsevier Inc. All rights reserved.Keywords: Extrachromosomal DNA; Persistent infection; Human papillomavirusIntroduction
Human papillomaviruses (HPVs) are small circular double-
stranded DNA viruses that establish long-term persistent
infections in squamous epithelial cells. The viral life cycle is
tightly linked with the differentiation state of the host cells. It is
thought that an early amplificational event occurs following virus
entry into basal-layer cells. The viral DNA persists as a nuclear
episome in infected cells. In the non-productive stage of
infection, HPVs replicate at low-copy number in mitotically
active basal-layer cells within stratified epithelia (Howley, 1996).⁎ Corresponding author. Nebraska Center for Virology, E128 Beadle Center,
University of Nebraska-Lincoln, 1901 Vine Street, Lincoln, NE 68588-0666,
USA. Fax: +1 402 472 8722.
E-mail address: Pangeletti2@unl.edu (P.C. Angeletti).
0042-6822/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2008.01.013In the suprabasal keratinocyte layers, the viral genome
undergoes amplification, which yields from 100 to 1000 viral
copies per cell. The percentage of differentiated cells that
amplify viral DNA is often very low (Flores et al., 2000).
Papillomaviruses utilize two viral factors, E1, a helicase, and
E2, a transcriptional activator and auxiliary replication factor
(Rabson et al., 1986; Ustav and Stenlund, 1991; Ustav et al.,
1991). The E1 protein forms hexamers and unwinds viral DNA
similarly to cellular helicases, such as Werner's (WRN) and
Bloom's (BLM) syndrome helicases and minichromosome
maintenance (MCM) proteins (Ellis et al., 1995; Fouts et al.,
1999; Kass et al., 1997; Mohaghegh et al., 2001; Patel and
Picha, 2000). E1 has homology to SV40 DNA helicase, and
TAg, and both proteins direct polα activity to their respective
origins (Clertant and Seif, 1984; Mansky et al., 1997; Park et al.,
1994). In the final phase of HPV infection, the virus amplifies
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produced (Howley, 1996).
HPV genomes can persist in proliferating keratinocytes for
years or decades. This persistent phase of the viral lifecycle is
characterized by detectable levels of viral genome but the
absence of virus production (Stubenrauch and Laimins, 1999) is
likely a strategy to evade immune surveillance. Maintenance of
viral episomes requires that newly synthesized DNAs be
faithfully partitioned to daughter cells during mitosis. A similar
strategy is employed by Epstein–Barr virus (EBV) and
Koposi's sarcoma-associated herpesvirus (KSHV). These
viruses maintain their genomes in dividing cells through the
function of a virally encoded anchoring protein, which links the
viral DNAs, via repeat binding sites, to host mitotic chromo-
somes (Ballestas et al., 1999; Ballestas and Kaye, 2001;
Harrison et al., 1994; Lupton and Levine, 1985; Sears et al.,
2004; Yates et al., 1984, 1985). The same scenario has also been
observed in bovine papillomavirus type 1 (BPV1). Several
studies in BPV1 have shown that the major players, E1 and E2,
are key players in replication along with multiple E2 binding
sites located in the long control region (LCR) (Abroi et al.,
2004; Bastien and McBride, 2000; Ilves et al., 1999; Piirsoo
et al., 1996; Ustav et al., 1991; Wu et al., 2000). However, some
studies suggest that BPV1 E1 contributes to viral establishment,
but is not required for the maintenance stage of viral life cycle
(Kim and Lambert, 2002).
The E2 viral protein contributes to genome persistence by
linking viral DNAs, through specific DNA binding sites
(ACCGN4CGGT), to mitotic chromosomal proteins via an
interaction with the E2 N-terminus (Abroi et al., 2004; Bastien
and McBride, 2000; Ilves et al., 1999; McBride et al., 2006).
This mechanism was first observed in BPV1 studies, in which
E2 was found to stably bind to mitotic chromosomes via a
cellular protein, bromodomain protein 4 (Brd4) (Baxter and
McBride, 2005; Baxter et al., 2005; McPhillips et al., 2005; You
et al., 2004). However, recent observations of mitotic chromo-
some interactions with E2 protein from multiple papilloma-
viruses have revealed that there is significant variation in the
timing of binding and the specificity to the binding partner,
Brd4 (McBride et al., 2006). The E2 proteins from α
papillomaviruses (HPV11, HPV16, HPV31 and HPV57) are
able to bind to mitotic chromosomes but only in telophase of
mitotic process (Oliveira et al., 2006). Further studies have
suggested that the chromosome attachment of HPV E2s is
independent of Brd4 since the Brd4-binding affinities of the E2s
are much lower than that of BPV1. Additionally, point muta-
tions in E2 that eliminate the Brd4 binding do not affect the
mitotic chromosomal localization of these proteins (McPhillips
et al., 2006). This indicates that HPVs, particularly in the alpha
genus, have evolved a different strategy to maintain and equally
distribute their genomes to daughter cells.
In the case of BPV1, a total of 17 E2 binding sites (E2BS) has
been identified; 12 of them are located within the LCR region (Li
et al., 1989). For efficient partitioning and long-term persistence
of episomal BPV DNA, an element containing at least 10
E2BSs, known as the minichromosome maintenance element
(MME) was needed (Piirsoo et al., 1996). This minimal numberof E2 binding sites sufficient to provide the minichromosome
maintenance function exceeds the number of sites generally
found in LCR of many HPV types. Taken together, E2 and its
binding sites, may provide maintenance/partitioning function in
HPVs with the accompaniment of cellular maintenance factors.
Thus, we hypothesized that stable maintenance of the HPV
genomes in proliferating cells requires additional cellular factors
for efficient retention and faithful segregation of their genomes.
In previous experiments in Saccharomyces cerevisiae, we
demonstrated that HPV16 genomes can be replicated and stably
maintained in the absence of any particular viral protein, notably,
E1 and E2 (Angeletti et al., 2002; Kim et al., 2005). The
existence of an E1 and E2-independent mode of replication and
maintenance of HPV is supported by mapping studies in yeast
(Kim et al., 2005; Kim and Lambert, 2002). In those studies,
elements, referred to as mtc elements, present outside LCR
sequence that could substitute for autonomously replicating
sequence (ARS) and centromere (CEN) function in yeast. The
results suggest that remaining cis-elements are recognized by
cellular factors and confer both replication and maintenance
functions to the viral genome.
In the present study, we confirm an E1- and E2-independent
mode of viral replication in human cells by using a series of
HPV16 deletion mutants. Those mutants that lack E1, E2, and
LCR sequences showed a comparable level of replication to the
wild type genome in short-term replication assays. This
experiment provided firm evidence that E1, E2 and E2BSs
were not entirely essential for viral replication and that the
requirement for viral factors could be supplanted by cellular
replication machinery, under certain conditions. We hypothe-
sized that undefined cis-elements outside the LCR, and
recognized by cellular factors, could confer a degree of
maintenance activity. In order to determine which regions of
the genome had intrinsic maintenance function, we performed a
complementation assay in mammalian cells using plasmids
containing HPV16 subgenomic fragments, an EGFP cassette,
with or without a previously defined human ARS (hARS)
(Masukata et al., 1993).We then tested each plasmid for short and
long-term extrachromosomal replication and we measured their
mitotic stability. The results described here support the concept
that HPVs make use of E1 and E2-independent cis-acting
replication and maintenance signals, which likely allows greater
regulation on copy number and segregation.
Results
E1 and E2-independent replication of HPV16
Recent studies in yeast showed that, under certain condi-
tions, HPV16 could replicate in the absence of functional E1
and E2 proteins (Kim et al., 2005). In order to confirm the E1
and E2-independent mode of replication of HPV16 in human
cells, we generated a series of HPV16 deletion mutants cloned
into a modified pUC19 vector, referred to pUCGFP that carries
an expression cassette of EGFP. A panel of HPV16 deletion
constructs was transiently transfected in HEK 293 cells in
parallel with a parental wild type HPV16 and vector alone. Low
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4 days after transfection and then subjected to overnight
digestion with DpnI and HindIII prior to Southern blot analysis
using pUCGFP as a probe. By these means, the input DNA
originated from bacteria that is sensitive to DpnI was
completely degraded. Only newly synthesized, DpnI-resistant,
plasmids were still intact and observed as linear DNAs on the
Southern blot when they were cleaved by HindIII (Fig. 1A). In
this experiment, a similar level of replication was observed in
most mutants compared to the wild type HPV16, even though
they lacked E1, E2 coding regions and the LCR sequence. This
result is in agreement with the data from the pervious studies in
yeast that give us the evidence of E1- and E2-independent modeFig. 1. E1 and E2-independent replication and episomal maintenance of HPV16
and its mutants. (A) Short-term replication of HPV1 and deletion mutants. 293
cells were transfected with pUCGFP containing entire HPV16 genome or its
mutant derivatives. Plasmids were harvested 4 days after transfection. DNA
samples were double-digested overnight with DpnI andHindIII prior to Southern
analysis. The left lane contains a control for the completeness of DpnI digestion
ofDNA that was extracted from bacteria. (B) Plasmid stability of HPV16 genome
and mutants. 293 cells were cotransfected with full-length HPV16 or its mutants
and pCDNA3.1 (+) that contains a neomycin-resistant gene. Cells were grown in
the presence of the drug, G418, for 2 weeks. After the drugwas removed, the cells
were cultured under nonseletive conditions for another 16 days. Meanwhile, the
GFP-positive cells were monitored by flow cytometry at 0, 6, and 11 days after
release from drug. The relative percent GFP-positive cells was calculated and
plotted against time. The loss rate of each plasmid was determined as percent
change of GFP-positive cell per cell generation.of replication. The same experiments were performed in HaCaT
and HeLa cells and similar results were achieved, but since
transfection efficiency was superior in 293 cells we chose to do
the analyses in 293 cells. Many other studies have used 293
cells to identify replication and maintenance elements in EBV
and KSHV (Skalsky et al., 2007; Yates et al., 2000).
Plasmid stability of HPV16 deletion mutants that lack E1 and
E2 coding regions
In order to assess the capability of wild type HPV16 and its
mutant derivatives to be stablymaintained inmammalian cells, the
plasmids were individually transfected into 293 cells along with
pCNDA3.1 (+) that confers G418 resistance. The drug-resistance
property of the transfected cells allows them to outgrow
untransfected cells under selective conditions. After transfection,
the cells were grown under selective conditions for 4 days to
enrich cells containing the plasmids and to allow plasmids to
become established. After removal of selection, the stability of
plasmids was evaluated by monitoring the remaining GFP-
positive cells in the total cell population over the course of at least
2 weeks. Using flow cytometry, we could measure percent of
GFP-positive cells at different time points over several cell
generations and the percent loss of GFP-positive cells per cell
generation was calculated (Fig. 1B). The change of GFP-positive
cells over time, which indicates the stability of plasmid, depends
on two main processes; replication and partitioning. If both
replication and partitioning of the GFP-containing plasmid occurs
in dividing cells, the number of GFP-positive cells remains
essentially unchanged. If only one mechanism takes place (either
replication or partitioning), the number of GFP-positive cells
should be decreasing. In the case of partitioning plasmids that lack
replicative activity, the number of GFP-positive cells should
remain constant over the course of only the first cell divisions.
After each cell division, even if partitioning is functional, the copy
number of the non-replicating plasmidswill fall below a detectable
level.As shown in Fig. 1B, the vector itself that did not contain any
segments of the viral genome was lost at a rate of 4% per cell
generation. In contrast, all derivative mutants of HPV16 showed
similar pattern of plasmid stability to that observed in wild type
with the lower loss rate compared to the vector alone. Again, the
mutants that lack E1, E2, and LCR regions were retained in the
cells for 16 days. Interestingly, the vector that carries only L1
sequence was efficiently maintained in mammalian in the absence
of selection for at least 16 cell generations. This suggests that the
maintenance of HPV16 genome is independent of the viral
proteins E1 andE2 and therefore the E2 binding sites aswell as the
viral origin of replication that are located within the LCR regions
are not required for the retention of plasmid in the cells. It is likely
that undefined cis-acting elements residing outside the LCR
regionwould be recognized by cellular factors and that confers the
stability of the plasmid.
Mapping of E2-independent maintenance function
In previous studies, it was discovered that PV genomes could
be stably maintained in human cells in the absence of functional
Fig. 2. Short- and long-term replication of HPV16 subgenomic DNA in the
pGAB1 vector. (A) DpnI-resistant newly synthesized DNAs were linearized
with XhoI and detected by Southern blot at 4 days posttransfection. XhoI-treated
DNAs that indicated copy number were electrophoresed alongside. At the far
left, DpnI-treated control DNA showed the completeness of DpnI cutting of
DpnI-sensitive DNA from bacteria. (B) Southern analysis of Hirt-extracted
DNAs at 11 days after transfection. (C) The stability of plasmids containing
HPV16 subgenomic fragments was demonstrated as the relative loss rate per cell
generation. The percent of GFP-positive cells was determined by flow
cytometry at different time points. The change in percent GFP-positive cells
per cell generation (loss rate) was computed relative to the first time point of
each transfection. The loss rates of each plasmid were normalized with that of
the most stable plasmid to obtain the relative loss rate per cell generation.
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and Lambert, 2002). To identify such elements, we created a
library of plasmids in which subgenomic fragments of the
HPV16 genome, generated by digestion with Sau3AI, were
inserted into pGAB1, a vector containing a human ARS
element, a neomycin-resistant gene, and an expression cassette
for EGFP under the strong constitutive CMV promoter. The
vector backbone carries the human ARS element to provide the
replication function in mammalian cells to ensure that loss of
plasmids over the course of the experiment was not due to lack
of such activity and to allow the identification of maintenance
function in regions where no replication function resides. To
examine whether this HPV16 library plasmids were able to
replicate in human cells, we performed a short-term replication
assay with DpnI treatment at 4 days after transfection. All
HPV16 subgenomic containing plasmids replicated in 293 cells
as efficiently as vector itself that does not harbor any segment of
HPV16 DNA (Fig. 2A). Similar observed replication efficien-
cies rule out the possibility of interference of replication
function in long-term maintenance assays. Therefore, the
HPV16 subgenomic fragments present in the pGAB1 vector,
that provides replication function, would be considered as
maintenance elements and this stability did not result from the
advantage of replication. We noted that there was a steady loss
of replication function after 10 days post-release from G418, yet
plasmids persisted as evidenced by Southern analysis and by the
presence of EGFP signal (Fig. 2B). The gradual loss of repli-
cation function and continued DNA persistence was witnessed
with all constructs to varying extents. To ensure that the
persisting non-replicating DNAs were not simply extracellular,
we washed transfect cells with PBS and subcultured them every
3 days. Cells were then externally treated with 1 U of DnaseI
prior to Southern analysis. In these experiments, persisting
plasmids were indeed intracellular and episomal for greater than
14 days.
To track the maintenance function imparted by elements in
HPV16 DNA, we conducted flow cytometry to quantify the
EGFP signal over the course of 10–14 days after cells were
released from the G418 selection. Thus, the loss of EGFP signal
represents plasmid the loss and indicates differences in relative
intrinsic stability of the plasmids in human cells. To analyze
plasmid stability, we calculated the loss of GFP-positive cells
per cell generation and normalized with that of the most stable
plasmid to obtain the relative loss rates. As shown in Fig. 2C,
the plasmids that carried certain parts of HPV16 genome were
more stably maintained than was pGAB1. Among the HPV16
library plasmids, six of the nine Sau3AI subgenomic fragments
(fragments A (nt 525–621), B (nt 622–870), C (nt 871–3,479),
F (nt 4538–5071), G (nt 5072–6150), H (nt 6151–6950) were
identified to support long-term maintenance as they exhibited
lower relative loss rates compared to vector alone. Those frag-
ments are located within two distinct regions in the HPV16
genome; the first region resides in the early genes lying from the
3′ portion of E6 ORF to the 5′ segment of E2 ORF (fragments A,
B, and C) and the other region is in the late genes that covers the
3′ end of L2 and the entire L1 ORF (fragment F, G, and H)
(Fig. 2C). Interestingly, these maintenance elements mapped in
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previously identified as maintenance elements in yeast system
(Fig. 5).
Four fragments within maintenance elements contain both
replication and maintenance functions
The plasmid library in pGAB1 backbone that is mentioned
above was used to map region of the HPV16 genome that
provides plasmid stability. Although all plasmids exhibited
similar replication efficiency, we cannot rule out the possibility
that some of these fragments would contain replication activity
since such elements have been mapped in HPV16 genome using
a yeast system. In order to identify replication elements in the
viral genome, we generated another plasmid library in the
absence of hARS by removing the hARS element from each
HPV16 library constructs that were made in pGAB1. These
plasmids allow us to identify the elements that support DNA
replication based on their ability to substitute for the function of
hARS. We tested whether these plasmids were able to replicate
in 293 cells using a short-term replication assay and found that
most of them replicated to differing extents (Fig. 4A). The short-
term replication assay showed the strongest initially detectable
levels of DpnI-resistant DNA in fragments A (nt 525–621), B
(nt 622–870), C (nt 871–3479), E (nt 4361–4519), F (nt 4538–
5071), G (nt 5072–6150), I (nt 7014–524) (Fig. 4A). However,
in long-term maintenance assays, using flow cytometry, we
found that plasmids harboring 4 subgenomic fragments were
lost at the slower rate compared to vector alone, pEGFP,
whereas those baring other fragments lost rapidly. The
fragments that contained both replication and moderate to
significant levels of maintenance function, included fragments
A (nt 525–621), B (nt 622–870), F (nt 4538–5071), G (nt 5072–
6150) (Fig. 4B). Interestingly, these fragments are located
within two regions in the viral genome that we identified as
maintenance elements using the pGAB1 vector (Fig. 2B). The
first region is in partial portion of E6 and E7whereas the other one
is in L2 and 5′ part of L1. We noted that the vector itself
(pUCGFP) had some replication activity and was maintained to
an extent over 10 days, however the regions A, B, F and G were
maintained to a greater degree than the vector alone.
Analysis of the HPV16 genome for maintenance factor binding
sites
We reasoned that factors that function in cellular chromo-
some maintenance are most likely to contribute to HPV
maintenance, either independently, or in conjunction with E2.
Therefore, we mapped the HPV16 genome, for the presence of
HMG, CENP-B, TRF, MAR/SAR and Topo II binding sites,
which others previously showed influence EBV maintenance
(Deng et al., 2002; Hung et al., 2001; Masumoto et al., 1989).
We discovered that the HPV16 genome contains high
concentrations of Topo II sites in the LCR, L1, L2 and E7
ORFs, as well as HMG sites overlapping in L1 and E1. In
addition, at least eight CENP-B binding sites were detected in
the early and late regions of the genome. Of particular interestare the locations of MARS in L2, overlapping flanked by TRF
binding sites. MAR elements are known to provide stability to
replicating episomes in human cells (Cossons et al., 1997;
Papapetrou et al., 2006) and mapping studies have identified
MARS in HPV16 in E6, E1, E5, L2, and L1-LCR regions (Tan
et al., 1998).
Discussion
To establish a persistent infection, HPVs gain access to mi-
totically active basal-layer keratinocytes where low-copy
replication begins. Viruses that replicate their DNA extrachro-
mosomally, such asHPVs, EBVandKSHV, possess high fidelity
mechanisms to maintain their genomes. The primary threats to
stability of viral genomes are loss by diffusion through the
nuclear pores, loss during mitosis, or by nuclease-mediated
decay, and integration into the host genome (Calos and
Sclimenti, 1998; Deng et al., 2002). Viruses combat these
problems by: (i) nuclear retention and compartmentalization of
genomes, thus protecting them from loss and degradation (Deng
et al., 2002; Hung et al., 2001; Jankelevich et al., 1992; Nielsen
et al., 2000; Swindle et al., 1999; van Brabant et al., 1999) and
(ii) improving segregation efficiency by attaching genomes to
mitotic machinery (Ikeno et al., 1998; Kanda et al., 2001;
Lehman and Botchan, 1998; Longtine et al., 1992).
During the maintenance phase, it is thought that low levels of
E1 and E2 proteins are expressed in the infected basal cells.
Given this and the fact that HPV genomes can persist for
decades, this raises the question of whether cellular factors have
a more prominent role in genome maintenance of HPVs than
previously expected.
BPV1 E2 has been shown to interact with a chromatin-
binding bromodomain protein (Brd4), thus implicating it as the
mitotic chromosome anchor point for viral genomes (McBride
et al., 2004; You et al., 2004). The resulting model proposed for
all PVs, is that chromosome anchoring allows equal partitioning
of newly synthesized DNAs to daughter cells (McBride et al.,
2004). E2 from BPV and many HPVs (types 1, 4, and 8) have
been shown to bind tightly to mitotic chromosomes. However,
α-HPVs (types 11, 16, 31 and 57) appear to bind mitotic
chromosomes to a much weaker extent (Oliveira et al., 2006). In
specific, α-HPV E2 proteins could be detected near chromo-
somes in prophase and telophase, but not in metaphase or
anaphase (Oliveira et al., 2006). A potential explanation for this
disparity could be that partitioning observed among the α-HPVs
could be dependent to a greater extent on cellular factors than
HPVs for which E2 binds mitotic chromosomes tightly. Recent
studies have shown that the interaction of E2 and Brd4 is not
required for genome partitioning of all papillomaviruses, given
by the fact that several HPV E2 proteins are capable of
associating with mitotic chromosomes in the absence of Brd4
binding. Mutations in E2 have been described that disrupt the
Brd4 interaction but do not affect the association of E2 with
mitotic chromosomes (McPhillips et al., 2006). Thus, segrega-
tion of HPVs by interaction with chromosomes may occur
through different cellular anchoring partners and the involve-
ment of E2 may differ between genotypes. Ultimately, the role
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work has shown that Brd4 functions as a chromatin-binding
transcriptional regulator and can function as a silencer
(McPhillips et al., 2006; Wu and Chiang, 2007; Wu et al.,
2006). Further studies have demonstrated that though Brd4 has
a role in transcription of viral genes, it is not required for
maintenance for all PVs.
In addition to Brd4, E2 has been shown to interact with a
cellular helicase (ChlR1), which was initially discovered by an
interaction with the yeast homologue of ChlR1 (Parish et al.,
2006). In further studies, siRNA downregulation of ChlR1
resulted in a lack of E2 association with mitotic chromosomes,
indicating a potential role for ChlR1 in loading of E2 onto
chromosomal anchoring sites. Furthermore, a mutant of BPV E2
(W130R), which does not associate with mitotic chromosomes
also fails to bind ChlR1 (Parish et al., 2006). Dao and colleagues
described anHPV11 E2 interaction with mitotic spindles leading
to an alternative model for E2-dependent genome segregation
(Dao et al., 2006; Van Tine et al., 2004). Although these models
disagree on the anchoring target for segregation, the role of E2 as
the tethering factor is well accepted.
Motivating our studies, was the dramatic disparity in the
number of E2BSs in PV genomes. For example, BPV1 has at
least 17 E2BSs, of which, at least 10 E2BSs are required for
stable replication, per a study by Piirsoo et al. (1996). In contrast,
α-HPVs usually have 4 E2BSs, only 3 of which are required for
stable replication (Stubenrauch et al., 1998). In addition, certain
regions of HPV16 genome have been shown to interact with
nuclear matrix that might be involved in nuclear retention of the
viral genome (Tan et al., 1998) These observations reinforce the
concept thatα-HPVsmay rely to a lesser extent on E2 than BPV1
for stable replication. We therefore, hypothesized that unknown
cis-elements, together with their cellular binding partners, con-
tribute to α-HPV maintenance. In our ongoing studies of HPVFig. 3. Plasmidmaps of pGAB1 and pGFP. (A) A representation of HPV16 subgenomic
linear map of the HPV16 genome with each of eight ORFs indicated by arrows and the
HPV16 Sau3AI subgenomic fragments (B) A map of pGAB1 used in identification
neomycin-resistance gene and an hARS element obtained from clone P1W1 (Masukata
subgenomic fragments were cloned into theHindIII site of pGAB1. (C) Themap of pGF
an hARS-negative version of pGAB1. HPV16 library constructs in pGFP backbone dreplication in yeast, we have found that 3 E2BSs are insufficient
to restore stability to an unstable yeast plasmid (ARS+ CEN−)
(unpublished data). Even in the presence of E2, E2BS-containing
plasmids lacking a CEN become integrated into the yeast
chromosome. In contrast, the HPV genome is stably maintained
in the absence of E2 in yeast, yet the addition of E2 increases the
copy number and improves genome stability. This indicates that
E2 requires additional cellular factors for stabilization of HPV
DNA and E2BSs alone, are not sufficient.
Our studies have defined cis-acting elements that provide a
measurable degree of stability to HPV genomes independently of
E1 and E2 functions. We created vectors that had either a com-
plementing replication element (hARS) or not, each containing
Sau3AI fragments of the HPV16 genome (Figs. 3A–C).
The pGAB1 plasmid, mentioned above, was used to map the
regions of the HPV16 genome that provides plasmid stability.
Although all plasmids exhibited similar replication efficiency, we
cannot rule out the possibility that some of these fragments would
contain replication activity since such elements have been
mapped in HPV16 genome using a yeast system. In order to
identify replication elements in the viral genome, we generated
another plasmid library in the absence of hARS by introducing
individual Sau3AI-HPV16 subgenomic fragments in pGFP, a
derivative vector of pGAB1 that lacks hARS portion (Fig. 3C).
This library plasmid allowed us to identify the elements that
support DNA replication based on their ability to substitute the
function of hARS.We tested whether these plasmids were able to
replicate in 293 cells using a short-term replication assay and
found that most of them replicated to varying extents. In a long-
termmaintenance assay using flow cytometry, the results revealed
that the vector itself was maintained somewhat over the course of
10 days. However, four subgenomic fragments inHPV16 genome
showed more stability with increasing of percent GFP-positive
cells over time. Interestingly, these fragments are located withinfragments derived from Sau3AI-treatedHPV16 genome. The top bar represents a
control region, LCR shown as a gray bar. The lines designated A to I represent the
of maintenance elements in HPV16 genome. pGAB1 contains an EGFP gene, a
et al., 1993). To obtain HPV16 library constructs in the pGAB1 backbone, HPV16
Pused in identification of replication elementswithin theHPV16genome. pGFP is
erived from removal of the hARS portion from pGAB1 plasmids.
Fig. 4. Identification of regions in HPV16 that is able to substitute for replication
element. (A) Short-term replication of HPV16 library constructs in pGFP vector.
Hirt-extracted DNA at 4 days posttransfection was analyzed by Southern blot
after overnight digestion with DpnI and XhoI. (B) The loss rates of each plasmid
were determined as the relative loss rate per cell generation. The loss rates of
each plasmid were compared to that of the most stable construct.
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maintenance elements. The first region is in partial portion of E6
and E7 whereas the other one is in L2 and 5′ part of L1.Fig. 5. Comparison of replication and maintenance elements mapped in yeast and hum
light gray bars. The dark beveled bars show significant replication and maintenanceOur mapping studies revealed that we mapped the HPV16
genome for the presence of cis-acting functions that could
complement replication and maintenance functions, normally
provided by the ARS and CEN elements in yeast plasmids (Kim
et al., 2005). In that study, we discovered that three regions
within HPV16 (nucleotides 871 to 3480, nucleotides 4538 to
5072, and nucleotides 6151 to 6951) were capable of providing
maintenance function to complement an ARS+/CEN− plasmid
vector (pPA94).
In the current study, we found that in the absence of the hARS
fragment, replication activity in HPV DNA segments could be
detected, above the level of the vector (pGFP), in fragments A
(nt 525–621), B (nt 622–870), C (nt 871–3478), E (nt 4361–
4519), F (nt 4538–5071), G (nt 5072–6150), and I (nt 7014–524)
(Figs. 4B and 5). Perhaps the strongest replication activity was
from fragments C and E. The fact that there is low-level
replication activity not driven by E1 or E2,may be consistent with
an alternate mode of replication. We discovered that at least four
fragments within the genome contain both replication and
maintenance functions in fragments A (nt 525–621), B (nt 622–
870), F (nt 4538–5071), G (nt 5072–6150) (Figs. 4B and 5).
These data indicates that intrinsic low-level replication function
could provide a wider range of copy control for HPV, depending
on the level of quiescence required to evade cell-mediated
immune responses present in the stratified epithelium. Further-
more, the assistance of cellular factors in viral DNA maintenance
has already been established in other viral systems.
Several studies using EBV OriP, have described multiple
cellular factors that influence maintenance of OriP plasmids.
Examples of recently described maintenance factors which
influence EBVOriP stability are telomere-repeat binding factor 2
(TRF-2), hRap1 and poly-ADP-ribose polymerase (tankyrase)
(Deng et al., 2002). It has also been shown that the histone-related
proteins, HMG and H1, when fused to EBNA-1 can complement
its N-terminal chromatin-binding function (Hung et al., 2001). A
nucleolar protein known as EBP2, which interacts with EBNA-1,
appears to be required for EBNA-1-dependent maintenance of
OriP plasmids (Kapoor et al., 2001). Furthermore, the cellularan cells. The replication and maintenance elements mapped in yeast are shown as
functions mapped in human cells in this study.
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binding sites and is known to bind the metaphase plate, has also
been implicated in OriP maintenance (Zhang and Nonoyama,
1994). Finally, OriP artificial chromosomes are known to be
stabilized by binding CENP-B (Masumoto et al., 1989).
The concept that evolves from our studies is that cellular
factors may impart a greater influence on HPV replication and
maintenance than previously expected. The fact that most HPVs
contain only 4 E2BSs, while BPV1 contains at least 17 E2BS,
suggests HPVs have evolved in a direction, to take greater
advantage of cellular factors for genome persistence. There is
evidence that extrachromosomal replicating DNA viruses make
use of well-conserved chromosomal maintenance proteins. For
example, EBV is now known to interact with multiple chromo-
somal maintenance proteins (TRF, H1 histones, Kid, metaphase
plate proteins, SMC, andCENP-B (Deng et al., 2002; Hung et al.,
2001; Masumoto et al., 1989). The detection of multiple MARS,
HMG, Topo II, TRF andCENP-B binding sites and the clustering
of multiple types of binding sites in the late region in HPV16
provide some potentially important candidates to consider as
cellular maintenance factors. Ultimately, these observations
suggest that there is likely to be more than mechanism by
which cellular factors influence HPV maintenance.
Materials and methods
Mammalian cells and transfection methods
Human embryonic kidney (HEK) 293, HeLa and HaCaTcells
were grown in Dulbecco's modified Eagle's medium supple-
mented with 10% fetal bovine serum in a 5% CO2 incubator at
37 °C. All transfections were performed using Dreamfect reagent
(Ozbiosciences), 2 μg of DNA and 4×105 cells in 6-cm plates.
Cells were seeded in plates for 16 to 24 h prior to transfection.Fig. 6. Map of the pUCGFP plasmid. pUCGFP was created from the plasmid pUC19
was cloned into the multiple cloning site (MCS). The wild type HPV16 and various m
at BamHI site.Plasmids and library constructions
To identify cis-elements in HPV16 that are responsible for
stability of viral genomes, we first created a vector that carries a
human autonomously replicating sequence (hARS) and an
enhanced green fluorescent protein (EGFP) cassette. The pGFP
vector was fused to a 4980-bp segment of hARS (from clone
P1W1) (Masukata et al., 1993) resulting in an hARS+ pGFP
vector (pGAB1) which is able to replicate autonomously in
human cells. HPV16 library constructs were then made by
cloning HPV16 subgenomic fragments into pGAB1 vector
(Fig. 3A). The HPV16 genome was digested with Sau3AI into
multiple fragments ranging in size from 2.6 Kb to 18 bp which
were cloned into the pGAB1 vector using linkers (top, 5′-CG-
AGCTAAGCTTGCAA-3′; bottom, 5′-GATCTTGCAAGCT-
TAGCTCG-3′; HindIII site (underlined)). Individual plasmids
containing each fragment of the HPV16 genome were isolated.
To map regions in the viral genome that conferred both
replication and maintenance functions, a second set of HPV16
library was constructed by removing the hARS from pGAB1
library plasmids by EcoRI.
To rule out any bias effects due to the SV40 promoter that
exists in the previous sets of HPV16 library, the third HPV16
library was created in pUC19 carrying an expression cassette of
EGFP gene. To generate an EGFP+ pUC19 vector, an entire
EGFP gene including CMV promoter was amplified from
pEGFP-C1 (Clontech) using 5′CMV (5′-GCATCCTCGAGG-
TAATCAATTACGGG-3′) and 3′GFP (5′-CGAAGCTT-
GAGCTCGAGATCTGAG-3′) primers containing XhoI site
(underlined). The PCR products was trimmed with XhoI and
directly inserted into pUC19 vector at the XhoI site. The
resultant vector was named pUCGFP. Then, the full-length
HPV16 genome that was excised from pEF399 with a BamHI
digest was ligated into pUCGFP at the BamHI site, resulting in. An expression cassette containing the EGFP gene, driven by a CMV promoter,
utants, with respective deletions, shown in diagram, were inserted into pUCGFP
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HPV16GFP, shown in Fig. 6, were made by multiple restriction
enzyme digestion to remove certain regions of HPV16 genome
and the remaining DNA was religated with T4 ligase. The
ΔMSC mutant was generated by deleting the fragment between
2 MscI sites of HPV16GFP that contains entire sequence of L2
coding region and part of the E2 gene 5′ region. ΔE1–E2 was
generated by deleting the StuI–BsaBI fragment of HPV16GFP
that contains E1 and E2 coding regions. ΔLCR-E2 was gen-
erated by deleting the StuI–PmlI fragment of HPV16GFP that
contains the E2 coding region through LCR.ΔL1 was generated
by deleting the PmlI–XbaI fragment of HPV16GFP that
contains 5′ end of L1 coding region. The last mutant, L1, was
created by deleting the SmaI–PmlI fragment of HPV16GFP and
left fragment in it.
Plasmid maintenance assay
The plasmid maintenance experiment was modified from the
protocol previously described by Vogel et al. (1998). HPV16
library plasmids were transfected into human cell lines using
Dreamfect. The media was changed 24 h after transfection to
remove excess DNAs and residual transfection reagent. On the
next day, the cells were treated with 0.5 mg/mg G418 to favor
the growth of transfected cells containing the plasmids that
confer G418 resistance. The EGFP-expressing cells were left
under selective conditions for 4 days to allow untransfected
cells to die. The surviving cells were released into nonselective
media for 10–14 days and periodically subjected to analysis by
flow cytometry for GFP and Southern blot analysis. In order to
determine the stability of the plasmids, the relative percentages
of EGFP positive cells were calculated and plotted versus the
period of time after cells were released from the drug. To obtain
the relative percentages of EGFP positive cells, the final
percentages of EGFP positive cells, at several time points of
sampling, were divided by the initial percentage of EGFP
positive cells at day 0 which is the first day cells were released
from selection media. We calculated the loss rate of GFP-
positive cells per cell generation and normalized with that of the
most stable plasmid to obtain the loss rates per cell generation.
Assay for plasmid DNA replication
Cells were plated in 100 mm dishes and transfected with 5 μg
of DNAs, while the cells were 50 to 70% confluent. The cells
were incubated with the DNAs for 24 h, then the media was
changed. For the short-term replication assay, plasmid DNAwas
isolated using the Hirt method (Hirt, 1967) at 4 days after
transfection. For the long-term replication assay, the transfected
cells were grown in media containing 0.5 mg/ml G418 for
4 days after transfection then released to media without the drug
for 10–14 days. DNA was isolated using the Hirt method. The
plasmids were double-digested for 16–24 h with DpnI and XhoI
for HPV16 library in pUCGFP, or with DpnI and XhoI for
HPV16 library in pGAB1 or pGFP. DNA samples were
electrophoresed in a 0.8% agarose gel then analyzed by
Southern blot using EGFP as a probe.Analysis of the HPV16 genome for maintenance protein
binding sites
TheHPV16 genomewas analyzed for perfectmatcheswith the
high-mobility-group (HMG) protein consensus binding site
(WWWWWWS) using the Fuzznuc program (http://bioweb.
pasteur.fr/seqanal/interfaces/fuzznuc.html). The frequency of
predicted HMG sites was plotted against the HPV16 genome
with the threshold setting of N10 sites per 100 nucleotides.
Similarly, topoisomerase II (Topo II) consensus sites (RNYNN-
CNNGYNGKTNYNY) were plotted with a threshold frequency
of N7 sites per 100 nucleotides. The presence of single binding
sites of centromere binding protein B (CENP-B; YTTCGTTG-
GAARCGGGA) and telomere-repeat factor (TRF; TTAGGTTA)
was plotted against the HPV16 genome. Matrix or scaffolding
attachment regions (MARS/SARS) were located in the HPV16
genome using the Marscan program (http://bioweb.pasteur.fr/
seqanal/interfaces/marscan.html).MARS aremade up of bipartite
sequence elements of 8 bp (AATAAYAA) and 16 bp (AWWR-
TAANNWWGNNNC) within a 200 bp distance from each other.
The can be on either strand of the DNA and can overlap (van
Drunen et al., 1999). In addition, we included previously reported
MAR locations mapped in HPV16 (Tan et al., 1998).
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